DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Torisel (Temsirolimus) - Dehydration - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dehydration (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Torisel (Temsirolimus) where reactions include dehydration. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Torisel side effects in 19 year old male

Reported by a physician from United States on 2012-06-25

Patient: 19 year old male, weighing 54.9 kg (120.8 pounds)

Reactions: Dehydration, Photophobia, Haemorrhage Intracranial, Hydrocephalus

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Temozolomide
    Dosage: 125 mg/m2, on days 1-5
    Administration route: Oral
    Indication: Ependymoma Malignant
    Start date: 2012-04-23
    End date: 2012-04-27

Torisel
    Dosage: 35 mg/m2, over 30 minutes on days 1 + 8
    Indication: Ependymoma Malignant
    Start date: 2012-04-23
    End date: 2012-04-23

Irinotecan HCL
    Dosage: 90 mg/m2, on days 1-5
    Administration route: Oral
    Indication: Ependymoma Malignant
    Start date: 2012-04-23
    End date: 2012-04-24



Possible Torisel side effects in 19 year old male

Reported by a physician from United States on 2012-05-30

Patient: 19 year old male, weighing 54.9 kg (120.8 pounds)

Reactions: Photophobia, Haemorrhage Intracranial, Dehydration, Hydrocephalus

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torisel
    Dosage: 35 mg/m2, over 30 minutes on days 1 + 8
    Indication: Ependymoma Malignant
    Start date: 2012-04-23
    End date: 2012-04-23

Temozolomide
    Dosage: 125 mg/m2, on days 1-5
    Administration route: Oral
    Indication: Ependymoma Malignant
    Start date: 2012-04-23
    End date: 2012-04-27

Irinotecan HCL
    Dosage: 90 mg/m2, on days 1-5
    Administration route: Oral
    Indication: Ependymoma Malignant
    Start date: 2012-04-23
    End date: 2012-04-24

Other drugs received by patient: Acetaminophen and Oxycodone HCL; Benadryl; Ondansetron; Suprax ^klinge^; Zantac



Possible Torisel side effects in 19 year old male

Reported by a physician from United States on 2012-05-30

Patient: 19 year old male, weighing 54.9 kg (120.8 pounds)

Reactions: Photophobia, Dehydration, Haemorrhage Intracranial, Hydrocephalus

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Irinotecan HCL
    Dosage: 90 mg/m2, on days 1-5
    Administration route: Oral
    Indication: Ependymoma Malignant
    Start date: 2012-04-23
    End date: 2012-04-24

Temozolomide
    Dosage: 125 mg/m2, on days 1-5
    Administration route: Oral
    Indication: Ependymoma Malignant
    Start date: 2012-04-23
    End date: 2012-04-27

Torisel
    Dosage: 35 mg/m2, over 30 minutes on days 1 + 8
    Indication: Ependymoma Malignant
    Start date: 2012-04-23
    End date: 2012-04-23

Other drugs received by patient: Acetaminophen and Oxycodone HCL; Zantac; Suprax ^klinge^; Benadryl; Ondansetron



Possible Torisel side effects in 71 year old male

Reported by a physician from Germany on 2012-04-24

Patient: 71 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Clostridium Test Positive, Anaemia, Pyrexia, Blood Electrolytes Decreased, Ascites, Escherichia Test Positive, Diarrhoea, Dehydration, Pleural Effusion, Bone Marrow Failure, Thrombocytopenia, Hypertriglyceridaemia, Iatrogenic Infection, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torisel
    Dosage: 50 mg, weekly
    Start date: 2012-02-02

Torisel
    Dosage: 175 mg, weekly
    Indication: Mantle Cell Lymphoma
    Start date: 2011-10-18
    End date: 2011-11-01

Torisel
    Dosage: 75 mg, weekly
    Start date: 2011-11-08
    End date: 2012-01-10



Possible Torisel side effects in 71 year old male

Reported by a physician from Germany on 2012-03-29

Patient: 71 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Clostridium Test Positive, Anaemia, Immunodeficiency, Blood Electrolytes Decreased, Ascites, Escherichia Test Positive, Diarrhoea, Dehydration, Pleural Effusion, Bone Marrow Failure, Thrombocytopenia, Renal Failure Acute, Hypertriglyceridaemia, Iatrogenic Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torisel
    Dosage: 75 mg, weekly
    Start date: 2011-11-08
    End date: 2012-01-10

Torisel
    Dosage: 50 mg, weekly
    Start date: 2012-02-02

Torisel
    Dosage: 175 mg, weekly
    Indication: Mantle Cell Lymphoma
    Start date: 2011-10-18
    End date: 2011-11-01



Possible Torisel side effects in 81 year old male

Reported by a physician from United States on 2012-03-28

Patient: 81 year old male

Reactions: Fatigue, Respiratory Failure, Dehydration, Decreased Appetite

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Sorafenib
    Dosage: unk
    Administration route: Oral
    Indication: Thyroid Cancer
    Start date: 2011-09-22
    End date: 2011-11-05

Torisel
    Dosage: unk
    Indication: Thyroid Cancer
    Start date: 2011-09-22
    End date: 2011-11-02



Possible Torisel side effects in 81 year old male

Reported by a physician from United States on 2011-12-21

Patient: 81 year old male

Reactions: Death, Fatigue, Dehydration, Decreased Appetite

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Torisel
    Dosage: unk
    Indication: Thyroid Cancer
    Start date: 2011-09-22
    End date: 2011-11-02

Sorafenib
    Dosage: unk
    Administration route: Oral
    Indication: Thyroid Cancer
    Start date: 2011-09-22
    End date: 2011-11-07



Possible Torisel side effects in 81 year old male

Reported by a physician from United States on 2011-11-23

Patient: 81 year old male

Reactions: Fatigue, Dehydration, Decreased Appetite

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Torisel
    Dosage: unk
    Indication: Thyroid Cancer
    Start date: 2011-09-22
    End date: 2011-11-02

Sorafenib
    Dosage: unk
    Administration route: Oral
    Indication: Thyroid Cancer
    Start date: 2011-09-22
    End date: 2011-11-07



Possible Torisel side effects in 69 year old male

Reported by a physician from Australia on 2011-11-22

Patient: 69 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Fatigue, Vomiting, Nausea, Diarrhoea, Dehydration, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torisel

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017